Back to Results
First PageMeta Content
Blindness / Diabetes / Bevacizumab / Diabetic retinopathy / Ranibizumab / Macular edema / Vascular endothelial growth factor / Macula of retina / Retina / Ophthalmology / Medicine / Health


Eylea outperforms other drugs for diabetic macular edema with moderate vision loss
Add to Reading List

Document Date: 2015-05-28 18:27:17

Open Document

File Size: 38,82 KB

Share Result on Facebook

Company

DRCR.net / New England Journal / /

Country

Columbia / United States / /

Currency

USD / /

Event

Judicial Event / /

Facility

National Eye Institute / Palmetto Retina Center / /

MedicalCondition

diabetic retinopathy / Macular edema / diabetic macular edema / diabetic eye disease / diabetes / /

MedicalTreatment

laser treatment / /

Organization

National Eye Institute / National Institute of Health / Palmetto Retina Center / Medicare / /

Person

Paul A. Sieving / John A. Wells / /

Position

driver / retinal specialist / lead author / Director / /

Product

Avastin / Lucentis / /

ProvinceOrState

South Carolina / /

PublishedMedium

the New England Journal of Medicine / /

Technology

laser / /

URL

http /

SocialTag